PriceTargets.com logo

Mobia Medical - MOBI Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $20.75
  • Forecasted Upside: 85.93%
  • Number of Analysts: 7
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$11.16 As of 08/31/2026 05:00 PM ET
▼ -0.18 (-1.59%)

This chart shows the closing price for MOBI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Mobia Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MOBI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MOBI

Analyst Price Target is $20.75
▲ +85.93% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Mobia Medical in the last 3 months. The average price target is $20.75, with a high forecast of $31.00 and a low forecast of $16.00. The average price target represents a 85.93% upside from the last price of $11.16.

This chart shows the closing price for MOBI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 7 polled investment analysts is to moderate buy stock in Mobia Medical. This rating has held steady since June 2026, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/4/2026
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/2/2026
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/1/2026
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
8/31/2026

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/12/2026Weiss RatingsInitiated CoverageSell (E-)
8/12/2026JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$15.00 ➝ $17.00
8/12/2026BTIG ResearchReiterated RatingBuy ➝ Buy$19.00
6/3/2026Zacks ResearchUpgradeHold
6/2/2026Wolfe ResearchInitiated CoverageOutperform
6/2/2026The Goldman Sachs GroupInitiated CoverageBuy$31.00
6/2/2026The Goldman Sachs GroupInitiated CoverageBuy$31.00
6/2/2026JPMorgan Chase & Co.Initiated CoverageOverweight$15.00
6/2/2026BTIG ResearchInitiated CoverageBuy$19.00
6/2/2026Bank of AmericaInitiated CoverageBuy$16.00
(Data available from 8/31/2021 forward)

News Sentiment Rating

0.71 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/2/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/4/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2026
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
6/2/2026
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2026
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2026
  • 7 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/31/2026

Current Sentiment

  • 7 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Mobia Medical logo
Mobia Medical Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc. is based in AUSTIN, Texas.
Read More

Today's Range

Now: $11.16
Low: $11.02
High: $11.43

50 Day Range

MA: $12.02
Low: $10.43
High: $14.63

52 Week Range

Now: $11.16
Low: $10.19
High: $15.29

Volume

101,439 shs

Average Volume

128,154 shs

Market Capitalization

$371.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Mobia Medical?

The following Wall Street analysts have issued reports on Mobia Medical in the last year: Bank of America Corporation, BTIG Research, JPMorgan Chase & Co., The Goldman Sachs Group, Inc., Wall Street Zen, Weiss Ratings, Wolfe Research, and Zacks Research.
View the latest analyst ratings for MOBI.

What is the current price target for Mobia Medical?

0 Wall Street analysts have set twelve-month price targets for Mobia Medical in the last year. Their average twelve-month price target is $20.75, suggesting a possible upside of 85.9%. The Goldman Sachs Group, Inc. has the highest price target set, predicting MOBI will reach $31.00 in the next twelve months. Bank of America Corporation has the lowest price target set, forecasting a price of $16.00 for Mobia Medical in the next year.
View the latest price targets for MOBI.

What is the current consensus analyst rating for Mobia Medical?

Mobia Medical currently has 1 sell rating, 1 hold rating and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for MOBI.

What other companies compete with Mobia Medical?

Other companies that are similar to Mobia Medical include Omnicell, Kestra Medical Technologies, CONMED, Tandem Diabetes Care and Alphatec. Learn More about companies similar to Mobia Medical.

How do I contact Mobia Medical's investor relations team?

Mobia Medical's physical mailing address is 2802 FLINTROCK TRACE SUITE 226, AUSTIN, TX 78738, US. The company's listed phone number is 855-628-9375 and its investor relations email address is [email protected]. The official website for Mobia Medical is www.mobia.com. Learn More about contacing Mobia Medical investor relations.